FDA Import Control Efforts To Be Aided By Trilateral Working Group
A U.S.-Canada-Mexico working group will cooperate on controlling illegal importation of prescription drugs into the U.S
You may also be interested in...
The National Community Pharmacists Association plans to discuss the possibility of warning media outlets against running ads promoting Canadian drugs during an upcoming meeting with FDA Commissioner McClellan
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials